Administration of the active compound tetrahydroxystilbene glucoside (TSG) derived from the Chinese herbal medicine Polygonum multiflorum Thunb, reversed both overexpression of α-synuclein, a small protein found in the brain, and its accumulation using a mouse [...]
Tag Archives | treatment
Chinese herb compound tetrahydroxystilbene glucoside (TSG) could prevent, treat Alzheimer’s
Breast cancer survivors at higher risk for falls
St. Louis, MO, March 4, 2011 — The combined effects of chemotherapy and endocrine therapy may increase the risk of bone fractures in breast cancer survivors. In a study scheduled for publication in the April issue of the Archives of Physical Medic…
New findings on drug tolerance in TB suggest ideas for shorter cures
New findings on how tuberculosis (TB) bacteria develop multi-drug tolerance point to ways TB infections might be cured more quickly.
The study will be published April 1 in the journal Cell. The results identify both a mechanism and a potenti…
Latest findings of Dartmouth HIV/AIDS study could turn treatment ‘on its head’
LEBANON, NH – A clinical study of anti-HIV/AIDS medicines in the developing world is on the verge of turning “the whole treatment world on its head,” according to Dartmouth pediatrician Paul Palumbo.
Palumbo, a professor of pediatric medicine at D…
Fighting cancer at your local Indian restaurant
Turmeric, a bright yellow spice from south Asia belonging to the ginger family, is the main ingredient in curries — and ancient wisdom suggests that it’s also good for your health. Taking this wisdom to the laboratory, Tel Aviv University r…
Discovery of source of glycogen ‘manufacturing’ errors sheds light on fatal disease
Indiana University scientists have solved a perplexing mystery regarding one of the body’s main energy storage molecules, in the process shedding light on a possible route to treatment of a rare but deadly disease in teenagers.
The disease occur…
New cell therapy a promising atherosclerosis treatment
Researchers at Karolinska Institutet have shown in a new study on mice, that cell therapy can be used to reverse the effect of ‘bad’ LDL cholesterol and reduce the inflammation that leads to atherosclerosis. The new cell therapy, which is presented …
CROI — Day 2: Selected highlights of NIH-supported research
The 18th Conference on Retroviruses and Opportunistic Infections is taking place at the Hynes Convention Center in Boston from February 27 through March 2. Day two of this major HIV/AIDS research conference included the following selected presenta…
Probiotic identified to treat ulcers
Researchers from Spain have identified a strain of probiotic bacteria that may be useful in treating ulcers caused by Helicobacter pylori. They report their findings in the February 2011 issue of the journal Applied and Environmental Microbiology.
…
Lack of health insurance limits hepatitis C patients’ access to latest antiviral therapy
New research has determined that patients in the U.S. with hepatitis C virus (HCV) are twice as likely to not have health insurance coverage compared with those without the disease. In fact researchers found only a third of HCV infected Americans ha…
Nanotechnology may lead to new treatment of liver cancer
Nanotechnology may open a new door on the treatment of liver cancer, according to a team of Penn State College of Medicine researchers. They used molecular-sized bubbles filled with chemotherapy drugs to prevent cell growth and initiate cell death i…
Drug therapy shows significant benefit in treating a leading cause of childhood blindness
A readily available, inexpensive drug therapy showed a significant benefit in treating premature infants with the worst and historically most difficult-to-treat cases of retinopathy of prematurity.
The results of a multicenter clinical trial…
Water softeners not found to improve childhood eczema
The first study of its kind in the world — involving 336 children aged between six months and 16 years old — has shown that installing a water softener for three months brings no additional relief for eczema sufferers.
Up to one fifth of all…
Whole genome sequencing used to help inform cancer therapy
SCOTTSDALE, Ariz. — Feb. 16, 2011 — Whole genome sequencing — spelling out a person’s entire DNA genetic code — has moved one step closer to being a medical option for direct patient care.
Physicians and researchers at Mayo Clinic in A…
UT Southwestern launches clinical trial for treatment of breast cancer using CyberKnife
DALLAS — Feb. 15, 2011 — Breast-cancer patient Kristin Wiginton is the first to be treated at UT Southwestern Medical Center with high-beam radiation using the Accuray CyberKnife System, which offers improved cosmetic results, less radiation exp…
Protein may be key to new treatment in a childhood cancer
After analyzing hundreds of proteins produced by the DNA of tumor cells, researchers have identified one protein that may be central to a new treatment for the often-fatal childhood cancer neuroblastoma. Oncologists hope to translate the finding int…
Older adults often excluded from clinical trials
Older individuals, who constitute a rapidly growing population in the United States, account for a disproportionate share of health care utilization and cost.
Yet more than half of clinical trials exclude people based on their age or age-related …
Painful hip fractures strike breast cancer survivors
CHICAGO — A hip fracture is not common in a 54-year-old woman, unless she is a 54-year-old breast cancer survivor, according to a new Northwestern Medicine study. Researchers found that a combination of early menopause due to breast cancer treatme…
Early tests find nanoshell therapy effective against brain cancer
HOUSTON — (Feb. 1, 2011) — Rice University bioengineers and physician-scientists at Baylor College of Medicine and Texas Children’s Hospital have successfully destroyed tumors of human brain cancer cells in the first animal tests of a minimally in…
Study finds little decline in hepatitis C infections among injection drug users
[EMBARGOED FOR JAN. 31, 2011] A recent 20-year study of injection drug users (IDUs) in Baltimore found a significant decline in new cases of HIV infection but only a slight decline in new cases of hepatitis C virus (HCV) infection. The findings sugg…
Ben-Gurion U. researchers determine that a first medical opinion can influence the second
BEER SHEVA, ISRAEL — January 27, 2011 — A new study by Ben-Gurion University of the Negev (BGU) researchers indicates that physicians who give second opinions may be influenced by the first opinion and other external factors.
In the study, the…
Study suggests possible new treatment for severe 2009 H1N1 infection
Convalescent plasma therapy — using plasma from patients who have recovered from an infection to treat those with the same infection — has been used to treat multiple diseases. However, the efficacy of this treatment in patients with severe 2009 …
RevaTen platelet-rich plasma shows promise as potential treatment for heart attacks
STANFORD, Calif. — Researchers at the Stanford University School of Medicine, in collaboration with BioParadox, Inc., have published data supporting the use of platelet-rich plasma as a promising biologic treatment for myocardial infarction (heart…
University of Oklahoma scientists discover way to stop pancreatic cancer in early stages
Cancer researchers at The Peggy and Charles Stephenson Oklahoma Cancer Center have found a way to stop early stage pancreatic cancer in research models — a result that has far-reaching implications in chemoprevention for high-risk patients.
…
Treating fractures: Children are not miniature adults
Treating fractures in children requires special knowledge of growth physiology. Incorrect treatment of bone fractures in child and adolescent patients is less often caused by technical deficiencies than by a misjudgment of the special conditions in …
Ben-Gurion U. researchers: High resistance rates among acute otitis media pathogens in children
BEER-SHEVA, ISRAEL, December 17, 2010 — As middle ear infections increase during the winter months, researchers from Ben-Gurion University of the Negev (BGU) suggest that in many cases the most appropriate treatment is “watchful waiting” instead …